A Study of Updated mRNA Seasonal Influenza Vaccines

StatusNot Yet Recruiting
PhasePhase 4
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Moderna
50 trials monitored
See 3 trials at risk
The purpose of this study is to evaluate the immunogenicity and safety of updated strain-containing compositions of the mRNA-1010 vaccines within the current epidemiological environment.
Trial Details
NCT Number NCT07884175
Lead Sponsor ModernaTX, Inc.
Conditions
(from sponsor)		 Seasonal Influenza
Related terms Influenza, Human
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov